Company intelligence / Profile preview

Believe International

Shanghai, Shanghai, Chinabeliever-bio.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Believe Bio-Med is a clinical-stage biotechnology company specializing in the development of innovative gene therapies using adeno-associated virus (AAV) vectors. Founded by gene therapy pioneer Dr. Xiao Xiao, the company focuses on treating rare diseases and chronic conditions with high unmet medical needs, including hemophilia and neuromuscular disorders. Its lead candidate, BBM-H901, is a Phase 3 gene therapy for Hemophilia B that has demonstrated significant efficacy and safety in clinical trials. Believe Bio-Med maintains integrated capabilities across vector design, process development, and large-scale GMP manufacturing, positioning itself as a leader in the Chinese gene therapy sector.

Therapeutic areas: HematologyNeurologyRare Diseases
Modalities: Gene therapy
Industry: Biotech

Beyond the preview

Go deeper on Believe International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Believe International.